Drawing for OPENEVIDENCE AI-INTEGRATED DOCTOR DIALER

USPTO serial 99675588

OPENEVIDENCE AI-INTEGRATED DOCTOR DIALER

Reviewed by CopyMark Law Group

Status 802
Filing date
Status date
Registration date
—
Examiner
SOMERVILLE, ARETHA CHARESE
Law office
PUBLICATION AND ISSUE SECTION

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with OPENEVIDENCE AI-INTEGRATED DOCTOR DIALER?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Lisa Greenwald-Swire

Lisa Greenwald-Swire Fish & Richardson, P.C.P.O. Box 1022Minneapolis, MN 55440-1022United States

Goods and services

ClassDescriptionStatusFirst use
044Providing medical and health information; Providing medical and health information via a global computer network; Providing an interactive computer database featuring medical and health information; Providing medical and health information generated by automatically synthesizing the information from a large comprehensive corpus; Providing a website featuring information on health and nutrition; Providing information over a global computer network in the fields of health and nutrition; Providing medical, health, and health care information; Providing medical information by way of a world wide web page accessible via global computer network; providing online health and medical information in the fields of fitness, nutrition, dieting, and wellness; Providing health and health care information over the internet; Providing health care information by global computer networks; Providing a website featuring health and medical information in the fields of healthcare, pharmaceuticals, fitness, nutrition, dieting, and wellness; Providing information relating to diagnostic, prophylactic and therapeutic properties of pharmaceuticals; medical consulting services for healthcare providers and researchers in the field of biomedical sciences; Medical services, namely, providing clinical data analysis for use by healthcare providers in connection with medical diagnosis and treatment; Medical services, namely, analyzing and providing clinical data to facilitate physician decision making for the diagnosis and treatment of persons; Medical consulting services rendered using artificial intelligence (AI) that delivers expert-level analysis on patient-specific cases as well as in-depth research and synthesis of user-specified domains within biomedical sciences for healthcare professionals and researchersACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Oct 1, 2026ETOFEXTENSION OF TIME TO OPPOSE RECEIVED—
Sep 8, 2026NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Sep 8, 2026PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Sep 2, 2026NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Aug 12, 2026CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Aug 11, 2026XAECEXAMINER'S AMENDMENT ENTERED—
Aug 11, 2026ALIEASSIGNED TO LIE—
Aug 5, 2026GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED—
Aug 5, 2026GNEAEXAMINERS AMENDMENT E-MAILED—
Aug 5, 2026CNEAEXAMINERS AMENDMENT -WRITTEN—
Jun 27, 2026DOCKASSIGNED TO EXAMINER—
Jun 26, 2026NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Feb 28, 2026MAFRAPPLICATION FILING RECEIPT MAILED—
Feb 28, 2026NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance